Literature DB >> 21045592

Prevention and treatment of HIV/AIDS among drug-using populations: a global perspective.

Elizabeth Y Lambert, Jacques L Normand, Nora D Volkow.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21045592      PMCID： PMC3074297          DOI： 10.1097/QAI.0b013e3181f9c120

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  18 in total

1.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

2.  Antiretroviral treatment 2010: progress and controversies.

Authors:  Roy M Gulick
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes.

Authors:  Julio S G Montaner; Evan Wood; Thomas Kerr; Viviane Lima; Rolando Barrios; Kate Shannon; Richard Harrigan; Robert Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 4.  Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs.

Authors:  Daniel Wolfe; Jonathan Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  HIV among people who use drugs: a global perspective of populations at risk.

Authors:  Jamila K Stockman; Steffanie A Strathdee
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 6.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

8.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

9.  Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

Authors:  Vikram S Gill; Viviane D Lima; Wen Zhang; Brian Wynhoven; Benita Yip; Robert S Hogg; Julio S G Montaner; P Richard Harrigan
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

10.  International consultation on the criminalization of HIV transmission: 31 October-2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007.

Authors: 
Journal:  Reprod Health Matters       Date:  2009-11
View more
  6 in total

1.  Rapid HIV testing in large urban jails.

Authors:  Curt G Beckwith; Amy Nunn; Sharon Baucom; Asresahegn Getachew; Akin Akinwumi; Bruce Herdman; Phil DiBartolo; Susan Spencer; Devon Brown; Henry Lesansky; Irene Kuo
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

2.  The feasibility of implementing the HIV seek, test, and treat strategy in jails.

Authors:  Curt Beckwith; Lauri Bazerman; Fizza Gillani; Liem Tran; Brita Larson; Saul Rivard; Timothy Flanigan; Josiah Rich
Journal:  AIDS Patient Care STDS       Date:  2014-03-11       Impact factor: 5.078

3.  Great Expectations: HIV Risk Behaviors and Misperceptions of Low HIV Risk among Incarcerated Men.

Authors:  C E Golin; B G Barkley; C Biddell; D A Wohl; D L Rosen
Journal:  AIDS Behav       Date:  2018-06

4.  NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.

Authors:  Susan Tross; Aimee N C Campbell; Donald A Calsyn; Lisa R Metsch; James L Sorensen; Steven Shoptaw; Louise Haynes; George E Woody; Robert M Malow; Lawrence S Brown; Daniel J Feaster; Robert E Booth; Raul N Mandler; Carmen Masson; Beverly W Holmes; Grant Colfax; Audrey J Brooks; Denise A Hien; Bruce R Schackman; P Todd Korthuis; Gloria M Miele
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

5.  How outpatient substance abuse treatment unit director activities may affect provision of community outreach services.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey Alexander; Sherri Green
Journal:  Drugs (Abingdon Engl)       Date:  2012-07-17

6.  A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.

Authors:  Kamini E Kuchinad; Heidi E Hutton; Anne K Monroe; Garrick Anderson; Richard D Moore; Geetanjali Chander
Journal:  BMC Res Notes       Date:  2016-04-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.